Cash · 2011–2025
Neogenomics cash
$160M−56.5% · FY2025
Neogenomics (NEO) reported $160M in cash for fiscal 2025, −56.5% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $160M | −56.5% | Open → |
| FY20242024-12-31 | $367M | +7.2% | Open → |
| FY20232023-12-31 | $342M | +30.1% | Open → |
| FY20222022-12-31 | $263M | −16.9% | Open → |
| FY20212021-12-31 | $317M | +38.5% | Open → |
| FY20202020-12-31 | $229M | +32.2% | Open → |
| FY20192019-12-31 | $173M | +1,663.5% | Open → |
| FY20182018-12-31 | $9.8M | −23.5% | Open → |
| FY20172017-12-31 | $12.8M | +2.4% | Open → |
| FY20162016-12-31 | $12.5M | −46.5% | Open → |
| FY20152015-12-31 | $23.4M | −30.5% | Open → |
| FY20142014-12-31 | $33.7M | +596.9% | Open → |
| FY20132013-12-31 | $4.8M | +158.8% | Open → |
| FY20122012-12-31 | $1.9M | −28.9% | Open → |
| FY20112011-12-31 | $2.6M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +34.1%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neogenomics cash |url=https://companiesranked.com/en/company/neogenomics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neogenomics cash. CompaniesRanked. https://companiesranked.com/en/company/neogenomics/cash-on-handBibTeX
@misc{companiesranked-en-company-neogenomics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Neogenomics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neogenomics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001077183-26-000059 · July 28, 2026
{{cite web |title=Neogenomics cash — 10-Q (0001077183-26-000059) |url=https://www.sec.gov/Archives/edgar/data/1077183/000107718326000059/neo-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-28}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.